Purpose: Foot pain is common, and associated with decreased ability to undertake activities of daily living, problems with balance and gait and increased risk of falls. However, few population-based studies have examined factors associated with foot pain in the general community. This study aimed to assess non-structural factors associated with foot pain both cross sectionally and longitudinally over 5 years, in a community dwelling sample of older adults. Methods: Longitudinal population-based cohort study of randomly selected older adults (n¼1040). Foot pain (yes / no) was assessed by questionnaire at baseline and after 5 years of observation. Potential correlates included demographic factors (age, sex, cigarette smoking), diabetes, anthropometry (weight, BMI, waist / hip ratio), lower leg strength (leg strength using dynamometer (kg), leg lean mass (kg), leg muscle quality (leg strength / leg lean mass)), steps per day (as assessed by pedometer), pain in the neck, shoulder, back, hands, hips, knees (all yes / no), the Psychological Wellbeing scale of Assessment of Quality of Life questionnaire (AQoL), and serum vitamin D. Logistic regression was used for cross-sectional associations with prevalent foot pain, and negative binomial regression for longitudinal associations with new foot pain. Results: Participants were aged 50-80 years (mean 63 years), 49% male, mean BMI 27.8±4.7 at baseline. Prevalence of foot pain at baseline was 37.7% (95% I 34.8 to 40.6%), incidence of new pain after 5 years was 19.6% (95% CI 16.1 to 23.1%). Persons with prevalent foot pain were more likely to be male, have poorer leg strength, higher weight and BMI, fewer steps per day, poorer psychological wellbeing, and number of non-foot sites with pain; all p<0.05. New foot pain was associated with male sex and the following at baseline: greater BMI and hip circumference, poorer leg muscle quality (leg strength / lower leg lean mass), poorer psychological wellbeing, and pain at more sites (other than feet); all p<0.05. Greater weight, poorer leg strength, pain at 3 or more sites, and poorer psychological quality of life were all associated with increased odds of foot pain at baseline (Table) . Similar factors were associated with increased risk of new foot pain developing over 5 years in people reporting no foot pain at baseline: greater weight, poorer leg strength, and pain at 3 or more sites (Table) . Psychological wellbeing was not an independent predictor of new knee pain after 5 years. Conclusions: Weight, poorer leg strength, and pain at other sites are consistently associated with prevalent foot pain and predict new foot pain. Poor psychological wellbeing is associated with existing foot pain. This suggests that weight reduction, improving leg strength, and taking a global approch to the treatment of pain may reduce the prevalence and incidence of foot pain in older adults.
IDENTIFICATION OF OA PAIN PHENOTYPES ASSOCIATED WITH STRUCTURAL PROGRESSION
A.R. Bihlet, I. Byrjalsen, J.R. Andersen, C. Christiansen, B.J. Riis, A.-C. Bay-Jensen, M.A. Karsdal. Nordic BioSci., Herlev, Denmark Purpose: Osteoarthritis (OA) is a heterogeneous disorder, with several possible drivers of disease progression. The degree of joint pain has been shown to be both diagnostic and prognostic for OA, but meaningful clinical characteristics to identify the group of patients at risk of rapid progression are still needed. The aim of this analysis was to identify key clinical characteristics indicating risk of disease progression through investigation of the association of radiographic progression over two years with baseline WOMAC pain baseline and the 5 different sub questions, with the aim of identifying OA pain phenotypes which may be associated with structural progression. Methods: A combined post-hoc analysis of two phase III RCTs (NCT00486434 and NCT00704847), both evaluating the efficacy and safety of oral salmon calcitonin in patients with painful knee OA (N¼2,206). Analysis of structural progression was made based on data from the placebo group, stratifying patients into quintiles of baselinereported WOMAC pain level and further investigating the 5 WOMAC pain subscale questions: A; during walking on a flat surface, B; using stairs (up or down), C at night while in bed, D; sitting or lying and E; while standing. Results: The level of reported pain was highly variable from min-tomax for all KL grades, underlining the disease heterogeneity in this patient population and perception of pain. 32% of target knees did not progress, and only 51% had changes over minimum significant change. The relation of WOMAC pain with progression was non-linear, hence patients with moderate pain progressing significantly more than those reporting mild or severe pain at baseline. Questions A and E were both independently, significantly correlated with progression (p¼ 0.05 and p¼0.005, respectively) whereas B, C and D were not (figure 1). These results indicate that acute, likely nociceptive, pain associated with walking and standing was more associated with progression than what may be interpreted as a possibly different, perhaps chronic inflammatory pain experienced without direct mechanical loading of the joint. Conclusions: These data from a large clinical trial dataset in OA describe significant associations between pain and pain subtypes and progression in OA, which may be related to different biochemical disease drivers. 
